<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>jmedicalcasereports</PublisherName>
      <JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
      <PISSN>I</PISSN>
      <EISSN>S</EISSN>
      <Volume-Issue>Volume 1; Issue 5</Volume-Issue>
      <PartNumber/>
      <IssueTopic>Multidisciplinary</IssueTopic>
      <IssueLanguage>English</IssueLanguage>
      <Season>(Sep-Oct, 2020)</Season>
      <SpecialIssue>N</SpecialIssue>
      <SupplementaryIssue>N</SupplementaryIssue>
      <IssueOA>Y</IssueOA>
      <PubDate>
        <Year>-0001</Year>
        <Month>11</Month>
        <Day>30</Day>
      </PubDate>
      <ArticleType>Medical Case Reports</ArticleType>
      <ArticleTitle>Incidental Finding of Mediastinal Mass in A Patient with A Confirmed Diagnosis of Moderate to Severe COVID-19: Case Report</ArticleTitle>
      <SubTitle/>
      <ArticleLanguage>English</ArticleLanguage>
      <ArticleOA>Y</ArticleOA>
      <FirstPage>1</FirstPage>
      <LastPage>8</LastPage>
      <AuthorList>
        <Author>
          <FirstName>Julián Rondón-Carvajal</FirstName>
          <LastName/>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>N</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Federico</FirstName>
          <LastName>Rodríguez-Vega</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Lucy</FirstName>
          <LastName>Pérez-Lugo</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Karina</FirstName>
          <LastName>Madera-Gutiérrez</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
          <FirstName>Fair</FirstName>
          <LastName>Clavijo-Tinoco</LastName>
          <AuthorLanguage>English</AuthorLanguage>
          <Affiliation/>
          <CorrespondingAuthor>Y</CorrespondingAuthor>
          <ORCID/>
        </Author>
      </AuthorList>
      <DOI/>
      <Abstract>Positive airway pressure ventilation systems are a therapeutic option in patients with confirmed SARS-CoV2 infection, who meet both clinical and biochemical criteria to be classified as moderate to severe cases, in order to avoid and / or delay progression to acute ventilatory failure. However, its success largely depends on a correct selection of the clinical setting. We present the case of a patient taken to non-invasive mechanical ventilation with slow positive end-expiratory pressure (PEEP) titration indicated in the event of persistent tachypnea despite correcting hypoxemia with conventional oxygen therapy, subsequently documenting a large mass in the anterior mediastinum, unknown to date. The patient had a favorable evolution from the clinical point of view. At the end, the eligibility criteria for considering the use of non-invasive mechanical ventilation in patients with COVID-19 will be discussed in a concise manner.</Abstract>
      <AbstractLanguage>English</AbstractLanguage>
      <Keywords>COVID-19, SARS-CoV-2, Mediastinal diseases, Non invasive positive pressure ventilation</Keywords>
      <URLs>
        <Abstract>https://jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=8163&amp;title=Incidental Finding of Mediastinal Mass in A Patient with A Confirmed Diagnosis of Moderate to Severe COVID-19: Case Report</Abstract>
      </URLs>
      <References>
        <ReferencesarticleTitle>References</ReferencesarticleTitle>
        <ReferencesfirstPage>16</ReferencesfirstPage>
        <ReferenceslastPage>19</ReferenceslastPage>
        <References>Alhazzani W, Mand;oslash;ller MH, Arabi YM. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med 2020; 46: 854-887.&#13;
&#13;
Ali I and Alharbi O. COVID-19: Disease, management, treatment, and social impact. The Science of the total environment 2020; 728: 138861.&#13;
&#13;
ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E. Acute respiratory distress syndrome. JAMA 2012; 307: 2526-2533.&#13;
&#13;
Bhimraj A, Morgan RL, Shumaker AH, Lavergne V, Baden L, Cheng VC, Edwards KM, Gandhi R, Muller WJ, O’Horo JC, Shoham S. Infectious diseases Society of America guidelines on the treatment and management of patients with COVID-19. Clin Infect Dis 2020; pp: 478.&#13;
&#13;
Chawla R, Dixit SB, Zirpe KG, Chaudhry D, Khilnani GC, Mehta Y, Khatib KI, Jagiasi BG, Chanchalani G, Mishra RC, Samavedam S. ISCCM guidelines for the use of non-invasive ventilation in acute respiratory failure in adult ICUs. Indian J Crit Care Med 2020; 24: S61-S81.&#13;
&#13;
Frat JP, Coudroy R, Marjanovic N, Thille AW. High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. Ann Transl Med 2017; 5: 297.&#13;
&#13;
Grieco DL, Menga LS, Raggi V, Bongiovanni F, Anzellotti GM, Tanzarella ES, Bocci MG, Mercurio G, Dell’Anna AM, Eleuteri D, Bello G. Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure. American journal of respiratory and critical care medicine 2020; 201: 303-312.&#13;
&#13;
Helviz Y, Einav S. A systematic review of the high-flow nasal cannula for adult patients. Critical care (London, England) 2018; 22: 71.&#13;
&#13;
Jin YH, Cai L, Cheng ZS, Cheng H, Deng T, Fan YP, Fang C, Huang D, Huang LQ, Huang Q, Han Y. A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020; 7: 4.&#13;
&#13;
Li Q, Zhu F, Xiao Y, Liu T, Liu X, Wu G, Zhang L. A Primary Mediastinal Large B-Cell Lymphoma Patient With COVID-19 Infection After Intensive Immunochemotherapy: A Case Report. Frontiers in Oncology 2020; 10: 924.&#13;
&#13;
Miller DC, Bime C, Partharsarathy S, Mosier JM. High-Flow Oxygen Therapy Concepts: Time to Standardize Nomenclature and Avoid Confusion. J Intensive Care Med 2020; 35: 519-523.&#13;
&#13;
Ministerio de Salud y Protecciand;oacute;n Social, Repand;uacute;blica de Colombia. Situaciand;oacute;n actual en Colombia: Nuevo Coronavirus (COVID-19), 20 de agosto de 2020. Sistema Integrado de Informaciand;oacute;n de la Protecciand;oacute;n Social (SISPRO). URL: https://sig.sispro.gov.co/SituacionCovid/&#13;
&#13;
Nasibova EM and Pashayev CN. The Use of Non-Invasive Ventilation (NIV) in the Treatment of Patients with COVID-19. J Intensive and; Crit Care 2020; 6: 5.&#13;
&#13;
Oand;#39;Brien T, Power DG. Mediastinal germ cell tumour during the COVID-19 pandemic. BMJ Case Reports CP 2020; 13: e237003.&#13;
&#13;
Patel BK, Kress JP, Hall JB. Alternatives to Invasive Ventilation in the COVID-19 Pandemic. JAMA 2020; 324: 43-44.&#13;
&#13;
Sarkar M, Niranjan N, Banyal PK. Mechanisms of hypoxemia. Lung India: official organ of Indian Chest Society 2017; 34: 47-60.&#13;
&#13;
Sternberg C, Andrade TL, Nova AP, Fiscina BV, Fernandes AP, Alves CD, Alves AB, Hizumi LO, Dias SS, Nobre P, Calabrich A. Oncology practice during COVID-19 pandemic: a fast response is the best response. Rev Assoc Med Bras 2020; 66(3):338-344.&#13;
&#13;
Tinelli V, Cabrini L, Fominskiy E, Franchini S, Ferrante L, Ball L, Pelosi P, Landoni G, Zangrillo A, Secchi A. High flow nasal cannula oxygen vs. conventional oxygen therapy and noninvasive ventilation in emergency department patients: a systematic review and meta-analysis. J Emerg Med 2019; 57: 322-328.&#13;
&#13;
Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. International Journal of Infectious Diseases 2020; 95: 304-307.&#13;
&#13;
Zhang G, Hu C, Luo L, Fang F, Chen Y, Li J, Peng Z, Pan H. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China. J Clin Virol 2020; 127: 104364.</References>
      </References>
    </Journal>
  </Article>
</ArticleSet>